文献速递妇科生殖医学

因双侧卵巢切除术导致早期或早发性绝经的瑞典女性绝经激素治疗使用不足:一项基于登记的研究

Insufficient use of menopausal hormone therapy in Swedish women with early or premature menopause caused by bilateral oophorectomy: a register-based study.
PubMed 文献 · BJOG · 2023-09-05

这项基于瑞典登记数据的回顾性队列研究纳入2005—2020年接受双侧卵巢切除术的35~44岁无恶性肿瘤女性,分析术后1年内至少一次领取绝经激素治疗(MHT)的比例及用药覆盖时间。全部1706例中1231例术后曾领取MHT,1177例在术后1年内领取;该比例从2005年的64%升至2019年的84%(p<0.001);全部人群平均用药覆盖时间仅43%,术后1年内领取者的覆盖时间为63%。作者认为应进一步研究该人群领取率低的原因,以提高对现行治疗指南的依从性。

要点

  • 1706例中1177例(69%)在双侧卵巢切除术后1年内领取MHT。
  • 术后1年内领取MHT的比例从2005年64%升至2019年84%(p<0.001)。
  • 全部人群平均用药覆盖时间43%,术后1年内领取者覆盖时间63%。

核心结论

  • 无恶性肿瘤女性接受双侧卵巢切除术后,仅69%在术后1年内领取MHT,且治疗持续时间有限。
  • 作者认为应进一步研究该人群MHT领取率低的原因,以提高对现行治疗指南的依从性、改善生活质量并避免发病率和死亡率增加。

研究设计与样本

  • 回顾性登记队列研究,数据来自瑞典妇科手术国家质量登记(GynOp)并与瑞典处方药登记中提取的发药数据交叉链接。
  • 纳入2005—2020年接受双侧卵巢切除术、年龄35~44岁、无恶性肿瘤的瑞典女性,共1706例。
  • 主要结局为术后1年内至少一次领取MHT的比例,并分析重复治疗时段及发药覆盖的‘人时’比例。

主要发现

  • 全部1706例中1231例在术后某时点领取MHT,其中1177例在术后1年内领取。
  • 术后1年内领取MHT的比例从2005年的64%升至2019年的84%(p<0.001)。
  • 全部人群共发生4537个‘治疗年’,相当于平均覆盖时间的43%。
  • 在术后1年内领取MHT的女性中,覆盖时间比例为63%。

临床怎么用

  • 作者认为应进一步研究该人群MHT领取率低的原因,以提高对现行治疗指南的依从性、改善生活质量并避免发病率和死亡率增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the use of menopausal hormone therapy (MHT) in premenopausal women after bilateral oophorectomy. DESIGN: Retrospective register-based cohort study. SETTING: Sweden. POPULATION: Swedish women aged 35-44 years without malignancy who underwent bilateral oophorectomy in 2005-2020 were identified using The Swedish National Quality Register of Gynaecological Surgery (GynOp). METHODS: Data from GynOp were cross-linked with data on dispensed drugs extracted from the Swedish Prescribed Drug Register. MAIN OUTCOME MEASURES: Proportion of women dispensed MHT at least once within 1 year after surgery. Repeated treatment episodes were defined, and the proportion of 'person time' covered by dispensations was analysed. RESULTS: In total, 1231 of all women (n = 1706) were dispensed MHT at some point after surgery, with 1177 women dispensed MHT within 1 year. This proportion increased from 64% in 2005 to 84% in 2019 (p < 0.001). In the total population, 4537 'treatment years' transpired, corresponding to 43% of the mean time covered. In women dispensed MHT within 1 year, the proportion of time covered was 63%. CONCLUSIONS: Only 69% of all women without malignancy of any kind who underwent bilateral oophorectomy were dispensed MHT within 1 year after surgery, and the duration of treatment was limited. It is important to study further the reasons behind the low dispensation rate in this group to increase adherence to current treatment guidelines, improve quality of life, and avoid increased morbidity and mortality.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Sundell M, Brynhildsen J, Fredrikson M, et al. Insufficient use of menopausal hormone therapy in Swedish women with early or premature menopause caused by bilateral oophorectomy: a register-based study. BJOG. 2023. PMID: 37667667. doi:10.1111/1471-0528.17647

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。